Hadasit Bio (HDST) — Cash Flow-to-Debt Ratio
Hadasit Bio (HDST) has a Cash Flow-to-Debt Ratio of -0.33x as of June 2022, meaning its operating cash flow of ILA-360.50K could theoretically repay 0% of its total liabilities (ILA1.10 Million) in one year. See working capital to net assets of Hadasit Bio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hadasit Bio Cash Flow-to-Debt Ratio (2013–2022)
Historical debt coverage capacity for Hadasit Bio across 10 annual periods. Also explore Hadasit Bio (HDST) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hadasit Bio (2013–2022)
Year-by-year debt coverage analysis for Hadasit Bio. For market capitalisation and broader financial context, see HDST company net worth.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.55x | ILA-2.12 Million | ILA3.88 Million | ▲ +81.2% |
| 2021 | -2.91x | ILA-2.10 Million | ILA722.00K | ▼ -213.7% |
| 2020 | -0.93x | ILA-3.96 Million | ILA4.27 Million | ▼ -14.1% |
| 2019 | -0.81x | ILA-3.18 Million | ILA3.91 Million | ▲ +94.9% |
| 2018 | -15.93x | ILA-16.46 Million | ILA1.03 Million | ▼ -608.0% |
| 2017 | -2.25x | ILA-17.57 Million | ILA7.81 Million | ▼ -20.1% |
| 2016 | -1.87x | ILA-14.68 Million | ILA7.84 Million | ▼ -17.4% |
| 2015 | -1.60x | ILA-13.26 Million | ILA8.31 Million | ▼ -34.3% |
| 2014 | -1.19x | ILA-12.24 Million | ILA10.31 Million | ▼ -1.0% |
| 2013 | -1.18x | ILA-11.61 Million | ILA9.87 Million | — |